Printer Friendly
The Free Library
14,680,088 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

The Neurotechnology Industry 2005: Reveals Brain Industry's Investment Opportunities, Risks and Competitive Landscape.


DUBLIN Dublin, city, Republic of Ireland
Dublin, Irish Baile Átha Cliath, county borough (1991 pop. 915,516), Leinster, capital of the Republic of Ireland, on Dublin Bay at the mouth of the Liffey River.
, Ireland Ireland, Irish Eire (âr`ə) [to it are related the poetic Erin and perhaps the Latin Hibernia], island, 32,598 sq mi (84,429 sq km), second largest of the British Isles.  -- Research and Markets (http://www.researchandmarkets.com/reports/c19099) has announced the addition of The Neurotechnology Neurotechnology is the set of tools that analyze and influence the human nervous system, especially the brain. These technologies include neural modeling simulations, biological computers, human-brain interfaces, any of various neuron and brain mapping technologies, and  Industry 2005 - Strategic Investment and Market Analysis report of the Global Neurological Disease Noun 1. neurological disease - a disorder of the nervous system
nervous disorder, neurological disorder

disorder, upset - a physical condition in which there is a disturbance of normal functioning; "the doctor prescribed some medicine for the disorder";
 and Psychiatric psy·chi·at·ric
adj.
Of or relating to psychiatry.


psychiatric adjective Pertaining to psychiatry, mental disorders
 Illness Markets to their offering.

The Neurotechnology Industry 2005 is the first report to provide a unified market-based framework to help investors, companies, and governments easily quantify Quantify - A performance analysis tool from Pure Software.  opportunities, determine risks and understand the dynamics of this rapidly growing market.

The report's findings include:

--Neurological disease and psychiatric illness represent the largest and fastest growing unmet un·met  
adj.
Not satisfied or fulfilled: unmet demands. 
 medical market: over 1.5 billion people worldwide and 100 million individuals in North America North America, third largest continent (1990 est. pop. 365,000,000), c.9,400,000 sq mi (24,346,000 sq km), the northern of the two continents of the Western Hemisphere.  alone;

--The neurotechnology industry has three sectors: neuropharmaceuticals with revenues of $87 billion and 13 percent growth annually; neurodevices with revenues of $2.8 billion and 20 percent growth annually; and neurodiagnostics with revenues of $12 billion and 11 percent growth annually;

--VC investment in neurotechnology companies climbed 225 percent from 1999 to 2004 representing nearly $6 billion. Today, one-in-four VC dollars invested in Life Sciences goes to neurotechnology companies;

"Neurotech companies are addressing the largest and fastest growing unmet medical market and the potential for high return investment has never been more compelling." - Mark Cochran, Managing Director, NeuroVentures Capital

This framework helps answer critical investment questions, such as:

--In what markets are neurodevices competing with neuropharmaceuticals?

--What impact is neuroimaging Neuroimaging
The use of x ray studies and magnetic resonance imaging (MRIs) to detect abnormalities or trace pathways of nerve activity in the central nervous system.

Mentioned in: Phobias

neuroimaging Imaging 1.
 having on drug development and disease diagnosis?

--Who is investing in neurotechnology and what types of startups are getting funded?

--How are public neurotech companies performing compared to other industries?

Report Highlights

--Profiles of more than 300 public and private neurotech companies

--A comprehensive analysis of 15 major neurological diseases and psychiatric illnesses including Alzheimer's disease Alzheimer's disease (ăls`hī'mərz, ôls–), degenerative disease of nerve cells in the cerebral cortex that leads to atrophy of the brain and senile dementia. , attention deficit hyperactivity disorder attention deficit hyperactivity disorder (ADHD), formerly called hyperkinesis or minimal brain dysfunction, a chronic, neurologically based syndrome characterized by any or all of three types of behavior: hyperactivity, distractibility, and impulsivity. , depression, anxiety, epilepsy epilepsy, a chronic disorder of cerebral function characterized by periodic convulsive seizures. There are many conditions that have epileptic seizures. Sudden discharge of excess electrical activity, which can be either generalized (involving many areas of cells in , addiction addiction: see drug addiction and drug abuse. , schizophrenia schizophrenia (skĭt'səfrē`nēə), group of severe mental disorders characterized by reality distortions resulting in unusual thought patterns and behaviors.  and pain

--The NeuroInsights' Neurotech Index: an investment benchmark that measures the stock performance of 30 publicly traded neurotechnology companies

--Profiles of the 10 most active neurotech venture capital firms Name Location Founding date Managing Partners/Directors Specialty Capital managed
5AM Ventures Menlo Park, CA; Waltham, MA 2002 John Diekman, PhD (managing partner), Scott Rocklage, PhD (managing partner), Andrew Schwab (managing partner) life sciences $200M [1]
, including investments by market segment

--Extensive discussion of the specific technological, demographic, regulatory, and intellectual property trends driving the global neurotech industry

--Analysis of the biological causes; current treatment options, emerging therapeutic strategies, and compounds in clinical trials by company, mechanism of action, and stage of development for each indication

Testimonials

"This is the first report to provide a comprehensive view of neurotechnology. It is a must read for any executive in the industry."

--Rodney Pearlman Pearlman (פרלמן) is a surname and may refer to:
  • Alan Pearlman
  • Adam Pearlman
  • Jeff Pearlman
  • Jordan Walker-Pearlman
  • Lou Pearlman
  • Michael Pearlman
, CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. , Saegis Pharmaceuticals

"A penetrating penetrating

breaching the tissues of the body.
 analysis of the complex industry that is bringing us new treatments for the brain and the mind."

--Samuel Barondes, Director, Center for Neurobiology Neurobiology

Study of the development and function of the nervous system, with emphasis on how nerve cells generate and control behavior. The major goal of neurobiology is to explain at the molecular level how nerve cells differentiate and develop their
 and Psychiatry psychiatry (səkī`ətrē, sī–), branch of medicine that concerns the diagnosis and treatment of mental, emotional, and behavioral disorders, including major depression, schizophrenia, and anxiety. , UCSF UCSF University of California at San Francisco

"Finally a complete view of companies, technologies and global trends driving neurotechnology. The Neurotechnology Industry 2005 fills a big gap that traditional CNS See Continuous net settlement.

CNS

See continuous net settlement (CNS).
 market and investment reports miss."

--Global Healthcare Group, Major Investment Bank

Companies Profiled
4-D NeuroImaging
aaiPharm
Abbott Laboratories
Acadia Pharmaceuticals
Accuray
Acorda Therapeutics
Acumen Pharmaceuticals
Addex Pharmaceuticals
Aderis Pharmaceuticals (formerly Discovery Therapeutics)
Adolor
Advanced Bionics
Advanced Brain Monitoring
Advanced Cochlear Systems
Advanced Neuromodulation Systems
Aegera Therapeutics
Aeolus Pharmaceuticals
Afferent Corporation
Afferon
AGY Therapeutics
Alexza
AlgoRx Pharmaceuticals
Alkermes
Allon Therapeutics
Alpha Omega Engineering
Alsius
Alza
Amarin Corporation
Amrad Corporation
Anagen Therapeutics
Ansata Therapeutics
Antigenics
Applied NeuroSolutions
Ardent Pharmaceuticals
ArmaGen Technologies
Armstrong Healthcare, Ltd.
Asilomar Pharmaceuticals
Aspect Medical Systems
AstraZeneca
Astro-Med
Athena Diagnostics
Athena Neuroscience
Athersys
Avera Pharmaceuticals
Aventis
Avigen
Axonyx
Bayhill Therapeutics
BioAxone Therapeutics
BioControl Medical, Ltd.
BioControl Systems
BioLineRX (formerly Bioline Therapeutics)
Bio-logic Systems Corp.
Boehringer Ingelheim
Boston Life Sciences
Boston Scientific
Brain Resource Company
BrainLAB
BrainsGate
Bristol-Meyers Squibb
Cadwell Laboratories
Capsant Neurotechnologies
Carlsson Research
CellMed
CeNeS Pharmaceuticals
Cephalon
Cerebral Vascular Applications
Cerebricon, Ltd.
Ceregene
Chiesi Farmaceutici
Chronogen
Clarus Medical
Cleveland Medical Devices
CoAxia
Cochlear, Ltd.
Cognetix
Cognosci
CogState, Ltd.
Compumedics, Ltd.
Concentric Medical
ConMed
Corcept Therapeutics
Cordis
Cortex Pharmaceuticals
CPS Innovations
CTI Molecular Imaging
Curis
Cyberkinetics
Cyberonics
Cypress Bioscience
DarPharma
Descartes Therapeutics
DOV Pharmaceutical
D-Pharm, Ltd.
DrugAbuse Sciences
Durect
Dynogen Pharmaceuticals
Eisai
Ekos
Elan
Electrical Geodesics
Elekta
Eli Lilly
Endo Pharmaceuticals
eNOS Pharmaceuticals
EnVivo Pharmaceuticals
Epic Biosonics
EpiCept
Epoch Innovations
ESPLORA
Ester Neurosciences
Eunoe
Everest Biomedical Instruments
Evotec Neurosciences
Eyetech Pharmaceuticals
Faust Pharmaceuticals
FineTech Medical
Forest Laboratories
Galileo Pharmaceuticals
GB Therapeutics, Ltd.
GE Healthcare
GenPath Pharmaceuticals
Geron
GlaxoSmithKline
Guilford Pharmaceuticals
GW Pharmaceuticals
H. Lundbeck
Helicon Therapeutics
Hormos Medical
Hunter-Fleming
Hydra Biosciences
Hypnion
Icagen
Ideon Corporation
IIP-Technologies
Imagine NeuroSolutions
Imagine Pharmaceuticals
Immusol
Indevus Pharmaceuticals
Ingenium Pharmaceuticals
Innercool Therapies
Inotek Pharmaceuticals
Ionix Pharmaceuticals
Integra
Janssen-Cilag
Jazz Pharmaceuticals
Johnson & Johnson
Juvantia Pharma
Kadmus Pharmaceuticals
KAI Pharmaceuticals
Kaleidos Pharma
Kosei
LA MONT Medical
Leptos
Lexicon Genetics
Lexicor Medical Technology
MAP Medical
Marinus Pharmaceuticals
MED-EL
Medimod Research Institute
MediVance
MedPointe Pharmaceuticals
Medtronic
Memory Pharmaceuticals
Merck
Metaphore Pharmaceuticals
Micro Therapeutics
MicroCHIPS
MicroStrain
MicroVention
Micrus
Migenix
MIICRO
MindGuard, Ltd.
Mindsense Biosystems
Mindset BioPharmaceuticals
Mitsubishi Chemical
Mitsubishi Pharma
Moberg Medical
Molecular Devices
MRC Systems
M's Science
Nastech Pharmaceutical
Neural Signals, Inc.
NeuraLieve
Neuralynx
Neuraxon
Neurion Pharmaceuticals
Neuro3d
Neurobiological Technologies
Neurochem
NeuroControl
Neurocrine
NeuroCure
Neurodan
Neurogen Corp.
NeurogesX
NeuroLogic
Neurome
NeuroMed Technologies
NeuroMetrix
Neuronetics
Neuronetrix
NeuroNexus Technologies
NeuroNova
Neuronyx
Neuronz, Ltd.
NeuroPace
NeuroSearch
Neurotech
Neurotrophic Bioscience
NeuroVasx
New River Pharmaceuticals
Newron Pharmaceuticals
Nicolet Biomedical
Nihon Kohden
NitroMed
Northstar Neuroscience
Novartis
NovaVision
Novosis
NPS Pharmaceuticals
NSGene
Nura
Nyxis Neurotherapies
Odin Medical Technologies
Olympus
Omneuron
Opexa Pharmaceuticals
Optobionics
Organon
Orphan Medical
Ortho-McNeil Pharmaceuticals
Oxford Instruments
Palomar Technologies
Pain Therapeutics
PainCeptor Pharma
Paion
Panacea Pharmaceuticals
Pfizer
Pharmalytics
Pharmavene
Pharmos
Pherin Pharmaceuticals
Philips Medical Systems
Physiometrix
Plexon
Posit Science
Positron Corporation
Predix Pharmaceuticals
Prescient NeuroPharma
Prestwick Pharmaceuticals
Proneuron Biotechnologies
Psychiatric Genomics
Psychogenics
Purdue Pharma
Questcor Pharmaceutical
Radiant Medical
Radionic's
Reata Discovery
Reckitt Benckiser
Regenecor
Regeneron Pharmaceuticals
ReNeuron
Renovis
RetinaPharma Technologies
Rinat Neuroscience
Rivanna Pharmaceuticals
Ruxton Pharmaceuticals
Saegis Pharmaceuticals
Sanofi-Aventis
Savient
Shering AG
Scientific Learning Corporation
Scion Pharmaceuticals
Seacoast Technologies
Second Sight Medical Products
Seimens Medical Solutions
Selva Medical
Sention
Sepracor
Sepracor's
Serenix Pharmaceuticals
Shire Pharmaceuticals
Shire's
SleepMed
Solstice Neurosciences
Somatocor Pharmaceuticals
Somaxon Pharmaceuticals
Somerset Pharmaceuticals
Somerset Pharmaceutical's
Sound Pharmaceuticals
Spectrum Pharmaceuticals
St. Croix Medical
StemCells
Stereotaxis
Sterix, Ltd.
Surface Logix
Synaptic Pharmaceutical
Synaptica, Ltd.
Synarc
Synergia Pharma
Synt:em
Targacept
Targeted Molecules Corporation
Tetragenix Pharmaceuticals
The Genetics Company
Theraptosis
Thuris
Titan Pharmaceuticals
Toennies
TorreyPines Therapeutics
Tomotherapy's
Touch EMAS
TransMolecular
Transneuronix
Tranzyme
Tucker-Davis Technologies
UCB
Valeant Pharmaceuticals
Valera Pharmaceuticals
Varian
Vasogen
Vela Pharmaceuticals
Vernalis
Vertis Neuroscience
VIASYS Healthcare
VIATRIS
Victhom Human Bionics
VSM MedTech
Wyeth
Xcel Pharmaceuticals
Xenome, Ltd.
Xenova Group
Xention Discovery, Ltd.
Yaupon Therapeutics
Zapaq
-0-


For more information visit http://www.researchandmarkets.com/reports/c19099
COPYRIGHT 2005 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2005, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Jun 13, 2005
Words:1054
Previous Article:Air France Holidays Introduces New 3 & 6-Night Paris Vacation Sale!
Next Article:CyMed, Inc., Honored as Top Emerging Technology Company in the Nation's Strongest Tech Market.



Related Articles
Raising your competitive IQ: The payoff of paying attention to potential competitors. (Competitive Intelligence).(associations)
VCs Have Brains on Their Mind: Neurotechnology Industry Experiencing Explosive Growth in Venture Funding Says Upcoming Report from NeuroInsights.
NeuroInsights Reveals Brain Industry's Investment Opportunities, Risks and Competitive Landscape in New Industry-Defining Report.
San Francisco, Boston, San Diego, and London Lead Global 'Brain Industry' Development, New NeuroInsights Study Shows; First Study of Neurotechnology...
John P. Donoghue Honored with Neurotech Business Report's ''Gold Electrode Award'' for Cyberkinetics' Groundbreaking BrainGate(TM) Brain-Computer...
NeuroInsights and BioToday Launch Neurotechnology Investment Newsletter in Japan; Neurotech Insights Helps Japanese Investors and Companies Profit...
Neurotechnology Revenues Reach $110 Billion Says New Report on the Brain Industry: NeuroInsights Reveals Investment Trends, Market Opportunities and...
Neurotechnology Revenues Reach $110 Billion Says New Report on the Brain Industry: NeuroInsights Reveals Investment Trends, Market Opportunities.
Acumen Joins Neurotechnology Industry Organization.
Neurotechnology Industry Organization Launched to Advance Treatments for Brain and Nervous System Illnesses.

Terms of use | Copyright © 2009 Farlex, Inc. | Feedback | For webmasters | Submit articles